• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cost-benefit and cost-effectiveness analysis in health care. Growth and composition of the literature.

作者信息

Warner K E, Hutton R C

出版信息

Med Care. 1980 Nov;18(11):1069-84. doi: 10.1097/00005650-198011000-00001.

DOI:10.1097/00005650-198011000-00001
PMID:6776353
Abstract

Concern about the escalating costs of health services is reflected in the rapid growth of the literature on cost-benefit and cost-effectiveness analysis (CBA and CEA, respectively) in health care. A search of that literature for 1966--78 produced a bibliography of more than 500 relevant references, growing from half a dozen per year at the beginning of the period to close to 100 each of the most recent 2 years. The literature growth has been more rapid in medical than nonmedical journals and a preference for CEA over CBA appears to be emerging. Studies related to diagnosis and treatment have gained in popularity, while the early prominence of studies with a substantive prevention theme has diminished. Consistent with the increasing medical focus of the literature, numbers of articles oriented toward individual practitioner decision making have grown more rapidly than those oriented toward organizational or societal decision making. In addition to documenting these trends, this article identifies published reviews of health care CBA/CEA and books and articles attempting to convey the principles of CBA/CEA to the health care community. The article concludes with speculation on likely near-future trends in the literature and consideration of the quality implications of the rapid growth.

摘要

相似文献

1
Cost-benefit and cost-effectiveness analysis in health care. Growth and composition of the literature.
Med Care. 1980 Nov;18(11):1069-84. doi: 10.1097/00005650-198011000-00001.
2
Health care CBA and CEA from 1991 to 1996: an updated bibliography.1991年至1996年医疗保健成本效益分析和成本效果分析:最新文献目录。
Med Care. 1998 May;36(5 Suppl):MS1-9, MS18-147. doi: 10.1097/00005650-199805001-00001.
3
Health care CBA/CEA: an update on the growth and composition of the literature.
Med Care. 1993 Jul;31(7 Suppl):JS1-11, JS18-149. doi: 10.1097/00005650-199307001-00001.
4
Methodologic principles of cost analyses in the nursing, medical, and health services literature, 1990-1996.1990 - 1996年护理、医学及卫生服务文献中成本分析的方法学原理
Nurs Res. 1999 Mar-Apr;48(2):94-104. doi: 10.1097/00006199-199903000-00008.
5
On-line access to a cost-benefit/cost-effectiveness analysis bibliography via CDC WONDER.通过美国疾病控制与预防中心的WONDER在线获取成本效益/成本效果分析文献目录。
Med Care. 1993 Jul;31(7 Suppl):JS12-7. doi: 10.1097/00005650-199307001-00002.
6
Cost-benefit and cost-effectiveness analysis of drug therapy.药物治疗的成本效益分析和成本效果分析。
Am J Hosp Pharm. 1985 Apr;42(4):791-802.
7
Use of number needed to treat in cost-effectiveness analyses.需要治疗人数在成本效益分析中的应用。
Ann Pharmacother. 2013 Mar;47(3):380-7. doi: 10.1345/aph.1R417. Epub 2013 Mar 5.
8
Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders预防和治疗精神、神经及物质使用障碍的干预措施、政策和平台的成本效益及可负担性
9
Assessing the cost-effectiveness of prevention.
J Community Health. 1983 Winter;9(2):145-65. doi: 10.1007/BF01349877.
10
Conditions for the near equivalence of cost-effectiveness and cost-benefit analyses.成本效益分析与成本效益分析近似等效的条件。
Value Health. 2002 Jul-Aug;5(4):338-46. doi: 10.1046/j.1524-4733.2002.54134.x.

引用本文的文献

1
Assessing cost-utility of predictive biomarkers in oncology: a streamlined approach.评估肿瘤学中预测性生物标志物的成本效益:一种简化方法。
Breast Cancer Res Treat. 2016 Jan;155(2):223-34. doi: 10.1007/s10549-016-3677-3. Epub 2016 Jan 9.
2
Cost-effectiveness of noninvasive ventilation for chronic obstructive pulmonary disease-related respiratory failure in Indian hospitals without ICU facilities.在印度没有重症监护病房设施的医院中,无创通气治疗慢性阻塞性肺疾病相关呼吸衰竭的成本效益。
Lung India. 2015 Nov-Dec;32(6):549-56. doi: 10.4103/0970-2113.168137.
3
Dairy foods and osteoporosis: an example of assessing the health-economic impact of food products.
乳制品与骨质疏松症:评估食品健康经济影响的范例。
Osteoporos Int. 2013 Jan;24(1):139-50. doi: 10.1007/s00198-012-1998-6. Epub 2012 Jun 16.
4
Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules.中低收入国家的成本效益:决策规则相关争议述评
Pharmacoeconomics. 2009;27(11):903-17. doi: 10.2165/10899580-000000000-00000.
5
Cost-effectiveness of neonatal surgery: first greeted with scepticism, now increasingly accepted.新生儿手术的成本效益:起初受到怀疑,如今越来越被接受。
Pediatr Surg Int. 2008 Feb;24(2):119-27. doi: 10.1007/s00383-007-2045-0. Epub 2007 Nov 6.
6
Costs of illness in cost-effectiveness analysis. A review of the methodology.成本效益分析中的疾病成本。方法学综述。
Pharmacoeconomics. 1994 Dec;6(6):536-52. doi: 10.2165/00019053-199406060-00007.
7
The effectiveness of cost-effectiveness analysis in containing costs.成本效益分析在控制成本方面的有效性。
J Gen Intern Med. 1998 Oct;13(10):664-9. doi: 10.1046/j.1525-1497.1998.00201.x.
8
Medical audit of rectal biopsy diagnosis of inflammatory bowel disease.炎症性肠病直肠活检诊断的医学审计
J Clin Pathol. 1982 Mar;35(3):341-4. doi: 10.1136/jcp.35.3.341.
9
Professional participation in organizational decision making: physicians in HMOs.
J Community Health. 1983 Spring;8(3):160-73. doi: 10.1007/BF01666451.
10
Discounting surgical benefits. Enucleation versus resection of the prostate.
J Med Syst. 1983 Dec;7(6):481-93. doi: 10.1007/BF00995179.